Acquisition of a powerful NMR machine for drug screening and structural biology
Official title: Acquisition of an 800 MHz NMR
Funded at Vanderbilt University · NIH-10851365 · Data updated 2026-11-12
This study is all about getting a new, powerful machine that helps scientists at Vanderbilt University better understand how drugs work with biological molecules, and it will also provide valuable training for students, especially those from diverse backgrounds in science.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Vanderbilt University NIH-funded |
| Lab location | 1 site (Nashville, UNITED STATES) |
| Project start | May 15, 2024 |
| Project end | May 14, 2026 |
| Funding year | 2024 |
| Award (this year) | $2,000,000 |
| NIH project number | 1S10OD034276-01A1 |
| Project ID | NIH-10851365 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for benefiting from this research include individuals with conditions that could be targeted by new drug therapies developed through enhanced screening methods.
✕Less likely to help
Patients with conditions that are not addressed by the specific drug discovery efforts enabled by this NMR technology may not receive direct benefits.
What this research studies
This research focuses on acquiring an advanced 800 MHz NMR spectrometer that will enhance drug screening and structural biology capabilities at Vanderbilt University. The new equipment will allow researchers to study complex interactions between biological macromolecules and improve the understanding of drug binding. It will also provide training opportunities for pre-doctoral and post-doctoral trainees, particularly those from underrepresented backgrounds in STEM. The project aims to support a wide range of NIH-funded research efforts in both basic and translational biomedical science.
Why it matters
Potential benefit: If successful, this research could significantly improve drug discovery processes and enhance our understanding of biological interactions, leading to better therapeutic options for patients.
How similar studies have gone: Other research has shown success with similar NMR technologies in advancing drug discovery and structural biology, indicating a strong potential for impactful outcomes.
Where this research is happening
-
Vanderbilt University
Nashville, United States Active
Researchers
- Principal investigator: Stone, Michael P — Vanderbilt University
- Study coordinator: Stone, Michael P
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.